“Grand View Research, Inc. – Market Research And Consulting.”
According to a report published by Grand View Research, The global DNA & gene chip market size was valued at USD 4.50 billion in 2017 and is projected to exhibit a CAGR of 11.4% during the forecast period.
According to a report, “DNA and Gene Chip Market Analysis Report By Product (Consumables, Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug Delivery, Genomics), By End Use, And Segment Forecasts, 2018 – 2025“, published by Grand View Research, Inc., The global size is expected to reach USD 10.7 billion by 2025, at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Key Takeaways from the report:
Based on product, consumables dominated the market with the largest share. This is due to presence of large number of entities engaged in providing reagents and kits associated with the use of DNA chips
The cancer treatment and diagnosis segment accounts for a significant share in the market owing to rising inclination toward development of companion diagnostics and growing usage of DNA microarrays in cancer diagnosis and treatment
Implementation of gene chip for drug discovery is also expected to increase in the coming years owing to growing demand for personalized medicine
By end use, academic/government research institutes accounted for the largest share in 2017. Ongoing research projects on gene expression analysis in these institutes have attributed for the estimated share
In terms of region, North America dominated the market with by revenue. High penetration of major revenue generating companies in U.S. has contributed to its leading share
Asia Pacific is projected to witness the fastest year-on-year growth owing to rising healthcare spending in developing economies and increase in R&D investment
Some of the prominent market participants are Agilent Technologies; Thermo Fisher Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen Inc.; and Arrayit Corporation. These players are engaged in mutual partnerships with research communities and other diagnostic firms for use of gene chips for targeting disease prognosis.
See AlsoDeltec Bank Bahamas says Deep Learning can help in Time Series Analysis and Sentiment AnalysisSurface Mining: The Next Booming Market in the World| Teck, Rio Tinto, VALE, BHP Billiton, Freeport-McMoranPredictive Analytics, Customized Solutions, Response Modeling, Churn Analytics are some of the Benefits of Artificial Intelligence in Banking, Says Deltec Bank – BahamasProfessional Service Robots Market is Going to Hit USD $182.0 Billion By 2027 | Grand View Research, Inc
Browse More Reports inBiotechnology Industry:
- Genome Editing Market : Utilization of the technique in achievement of therapeutic genetic editing in infected cells and tissues, thereby removing deleterious mutations is anticipated to boost market with potential growth opportunities.
- Orthobiologics Market : The global orthobiologics market size was valued at USD 5.0 Billion in 2015 and is expected to witness a CAGR of 7.5% during the forecast period.
Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.
Continuous development of new tools to support and enhance reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.
Grand View Research has segmented the global DNA & gene chip market on the basis of application, product, end use, and region:
DNA & Gene Chip Application Outlook (Revenue, USD Million, 2014 – 2025)
Cancer diagnosis and treatment
Gene expression
Genotyping
Genomics
Drug discovery
Agricultural biotechnology
Others
DNA & Gene Chip Product Outlook (Revenue, USD Million, 2014 – 2025)
Consumables
Instrumentation
DNA & Gene Chip End-use Outlook (Revenue, USD Million, 2014 – 2025)
Academic & Government Research Institutes
Hospitals & Diagnostics Centers
Biotechnology & Pharmaceutical Companies
Others
DNA & Gene Chip Regional Outlook (Revenue, USD Million, 2014 – 2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Middle East & Africa
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grad View Research, Inc.
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/dna-gene-chip-market
